Security key
78349D107
RxSight, Inc. - Common Stock, par value $0.001 per share (RXST)
CUSIP: 78349D107
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 7,920,040
- Total 13F value
- $100,348,000
- Share change
- +7,920,040
- SEC-reported price per share
- $12.67
- Number of holders
- 39
- Value change
- +$100,348,000
- Number of buys
- 39
- Shares outstanding
- 41,457,800
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
39
Top holders
10
RXST full security history
Ownership snapshot
Full 13F holder table
RxSight, Inc. SEC filings
RxSight, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RXST - RxSight, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RxSight I, LLC
Disclosed value leader
RxSight I, LLC
Comparable rows
0/5
Latest evidence
03 Aug 2021
3/4/5
Highest disclosed value: $96,806,554
5 rows are not safely comparable across share classes.
Quick read
RxSight I, LLC has the largest disclosed position value at $96.81M.
0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RxSight I, LLC's linked filing trail.
Disclosed position value
Top 5
RxSight I, LLC
$96.81M
RA CAPITAL MANAGEMENT, L.P.
$10.27M
Richard M. Wolfen
$88.33M
Bruce C. Robertson
$66.48M
Daniel Mark Schwartz
$19.57M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-5 of 5 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RxSight I, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$96,806,554
2,016,778 shares
|
— | 03 Aug 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$10,265,312
213,858 shares
|
— | 03 Aug 2021 |
| Richard M. Wolfen |
3/4/5
Director
|
—
class O/S missing
|
$88,332,816
1,840,244 shares
|
— | 03 Aug 2021 |
| Bruce C. Robertson |
3/4/5
Director
|
—
class O/S missing
|
$66,482,607
1,385,037 shares
|
— | 03 Aug 2021 |
| Daniel Mark Schwartz |
3/4/5
Director
|
—
class O/S missing
|
$19,567,301
407,647 shares
|
— | 03 Aug 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
7,920,040
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
0
Q3 2021 holders
39
Holder diff
39
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|